Inventor · disambiguated record
Marie Eugenie Migaud
Also filed as: MIGAUD MARIE · MIGAUD MARIE E · MIGAUD MARIE EUGENIE
19 granted patents·10 pending applications·76 citations·filing 2014–2025
93Inventor score
Top patents by PatentIndex Score
29 records- 0195US9975915B1Crystalline forms of nicotinoyl ribosides, modified derivatives thereof, and phosphorylated analogs thereof, and methods of preparation thereofUNIV BELFAST·Filed 2017·Granted May 22, 2018·21 cites·30 claims
- 0293US11274117B2Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereofUNIV BELFAST·Filed 2021·Granted Mar 15, 2022·3 cites·23 claims
- 0393US11242364B1Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereofUNIV BELFAST·Filed 2021·Granted Feb 8, 2022·3 cites·39 claims
- 0492US10689411B2Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereofUNIV BELFAST·Filed 2017·Granted Jun 23, 2020·4 cites·19 claims
- 0592US10000519B2Methods of preparing nicotinamide riboside and derivatives thereofUNIV BELFAST·Filed 2014·Granted Jun 19, 2018·20 cites·29 claims
- 0689US10815262B2Methods of preparing nicotinamide riboside and derivatives thereofUNIV BELFAST·Filed 2018·Granted Oct 27, 2020·2 cites·20 claims
- 0788US10000520B2B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereofCHROMADEX INC·Filed 2017·Granted Jun 19, 2018·6 cites·9 claims
- 0888US2024239831A1Methods of preparing reduced nicotinamide riboside and derivatives thereofUNIV BELFAST·Filed 2024·Application pending·0 cites
- 0987US12252506B2Methods of preparing nicotinamide riboside and derivatives thereofUNIV BELFAST·Filed 2023·Granted Mar 18, 2025·0 cites·43 claims
- 1086US11584770B2Methods of preparing nicotinamide riboside and derivatives thereofUNIV BELFAST·Filed 2020·Granted Feb 21, 2023·1 cites·19 claims
- 1186US10934322B2B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereofCHROMADEX INC·Filed 2018·Granted Mar 2, 2021·4 cites·18 claims
- 1284US10280190B2Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditionsCHROMADEX INC·Filed 2016·Granted May 7, 2019·6 cites·26 claims
- 1382US12195494B2Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereofUNIV BELFAST·Filed 2023·Granted Jan 14, 2025·0 cites·19 claims
- 1482US10183036B2Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursorsCHROMADEX INC·Filed 2017·Granted Jan 22, 2019·6 cites·8 claims
- 1581US11981698B2Methods of preparing reduced nicotinamide riboside and derivatives thereofUNIV BELFAST·Filed 2022·Granted May 14, 2024·0 cites·44 claims
- 1677US11345720B2Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereofUNIV BELFAST·Filed 2021·Granted May 31, 2022·0 cites·24 claims
- 1776US2025163093A1Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereofUNIV BELFAST·Filed 2025·Application pending·0 cites
- 1870US11746123B2Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereofUNIV BELFAST·Filed 2020·Granted Sep 5, 2023·0 cites·17 claims
- 1963US2025099496A1Dihydronicotinamide Riboside (NRH) Therapy for Osteoarthritis and other ConditionsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 2063US2025171482A1Deacylation of carbohydrate compoundsELYSIUM HEALTH INC·Filed 2023·Application pending·0 cites
- 2162US2025127804A1Ribose linkers and conjugates thereofELYSIUM HEALTH INC·Filed 2023·Application pending·0 cites
- 2260US2024415862A1Methods for treatment of menopausal syndromesELYSIUM HEALTH INC·Filed 2022·Application pending·0 cites
- 2354US2022347264A1Use of fkbp-l polypeptides and nucleic acids for the treatment of obesityROYAL COLLEGE SURGEONS IRELAND·Filed 2022·Application pending·0 cites
- 2452US11376308B2Use of FKBP-L polypeptides and nucleic acids for the treatment of obesityUNIV BELFAST·Filed 2017·Granted Jul 5, 2022·0 cites·3 claims
- 2542US11633421B2Use of NAD precursors for improving maternal health and/or offspring healthUNIV IOWA RES FOUND·Filed 2017·Granted Apr 25, 2023·0 cites·16 claims
- 2642US2022296623A1Reduced nicotinamideribosides for treating or preventing kidney diseaseNESTLE SA·Filed 2020·Application pending·0 cites
- 2740US2022323468A1Reduced nicotinamideribosides for the treatment/prevention of liver diseaseNESTLE SA·Filed 2020·Application pending·0 cites
- 2836US11071747B2Use of NAD precursors for breast enhancementUNIV IOWA RES FOUND·Filed 2017·Granted Jul 27, 2021·0 cites·14 claims
- 2936US2016355539A1Selective solvent free phosphorylationCHROMADEX INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marie Eugenie Migaud files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →